Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer
Imagene’s proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes…
Imagene’s proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes…
C2i Genomics and Premier Bringing AI-Powered Cancer Detection and Treatment Monitoring to Providers C2i Genomics, a cancer intelligence company,…